RxDoctor Payments Data

Brooke Draper, APRN

Primary Care · Lehi, UTNPI 1255021994

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 38.1% of the total.

$2,000in general payments, 2019–2025

Across 94 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$763
  • AstraZeneca$275
  • Boston Scientific$200
  • Novo Nordisk$123
  • Johnson & Johnson$98
  • Boehringer Ingelheim$79
  • plus $462 from 14 others

What the payments were for

  • Food & beverage$2,000100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,000 in reported general payments places this provider in the 75th percentile of 60 primary care providers in Utah.

See all primary care providers in Utah

Medicare billing

Part B allowed, 2024
$8,730
Medicare patients
59
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,296
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine16$524
Venlafaxine Hcl ErVenlafaxine Hcl14$352
Bupropion XlBupropion Hcl12$304
Levothyroxine Sodium28$261
Albuterol Sulfate HfaAlbuterol Sulfate11$240
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$179
Trazodone Hcl17$101
Metformin Hcl11$82
Amlodipine Besylate11$69
Cephalexin13$67
Azithromycin15$58
Prednisone15$17
Rosuvastatin Calcium13$13

Paid to pharmacies, not to this prescriber.

Other primary care in Lehi

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →